about
Photoaffinity labeling with cholesterol analogues precisely maps a cholesterol-binding site in voltage-dependent anion channel-1.Click Chemistry Reagent for Identification of Sites of Covalent Ligand Incorporation in Integral Membrane Proteins.Kinetic and structural determinants for GABA-A receptor potentiation by neuroactive steroids.A propofol binding site on mammalian GABAA receptors identified by photolabelingMultiple Non-Equivalent Interfaces Mediate Direct Activation of GABAA Receptors by Propofol.11-trifluoromethyl-phenyldiazirinyl neurosteroid analogues: potent general anesthetics and photolabeling reagents for GABAA receptors.The neurosteroid 5β-pregnan-3α-ol-20-one enhances actions of etomidate as a positive allosteric modulator of α1β2γ2L GABAA receptorsMutational Analysis of the Putative High-Affinity Propofol Binding Site in Human β3 Homomeric GABAA Receptors.Characteristics of concatemeric GABA(A) receptors containing α4/δ subunits expressed in Xenopus oocytes.Long-term cognitive decline in older subjects was not attributable to noncardiac surgery or major illness.The influence of the membrane on neurosteroid actions at GABA(A) receptors.Neurosteroid analogues. 18. Structure-activity studies of ent-steroid potentiators of γ-aminobutyric acid type A receptors and comparison of their activities with those of alphaxalone and allopregnanolone.Anesthetic Neurotoxicity: New Findings and Future Directions.Neurosteroid analogues. 15. A comparative study of the anesthetic and GABAergic actions of alphaxalone, Δ16-alphaxalone and their corresponding 17-carbonitrile analogues.Activation and modulation of recombinant glycine and GABAA receptors by 4-halogenated analogues of propofol.Increased risk of intraoperative awareness in patients with a history of awareness.Mapping Two Neurosteroid Modulatory Sites in the Prototypic Pentameric Ligand Gated Ion Channel GLIC.Anesthetic neurotoxicity--clinical implications of animal models.SmartTots Update Regarding Anesthetic Neurotoxicity in the Developing Brain.High constitutive activity accounts for the combination of enhanced direct activation and reduced potentiation in mutated GABAA receptors.Protamine relaxes vascular smooth muscle by directly reducing cytosolic free calcium concentrations in small resistance arteries.The Fallacy of Persistent Postoperative Cognitive Decline.Multiple functional neurosteroid binding sites on GABAA receptorsEnhanced GABAergic actions resulting from the coapplication of the steroid 3α-hydroxy-5α-pregnane-11,20-dione (alfaxalone) with propofol or diazepam.Congratulations from the IARS!Leadership in postgraduate medical educationPostoperative cognitive decline: the unsubstantiated phenotypeThe molecular determinants of neurosteroid binding in the GABA(A) receptorMultiple neurosteroid and cholesterol binding sites in voltage-dependent anion channel-1 determined by photo-affinity labelingCommon binding sites for cholesterol and neurosteroids on a pentameric ligand-gated ion channelIn ReplyIn replyThe GAS trial
P50
Q30152640-20E1659C-AF19-47D9-8A7E-79018D7D4C1DQ30398567-636C9FB1-C8DF-4357-A9FF-DE1E330F5248Q33836921-88A25867-7826-4728-8136-310E2C6386BEQ34372642-26FFD12C-F3CE-40EF-BF22-B7B5D0004803Q34511713-89CE87B3-581B-469F-B2DA-973428B80CFDQ34682219-682D6971-5D1D-48EB-800F-7BEBACBCB2D2Q34953451-53395A45-A2A8-4B6D-A59D-2FB8B245D75EQ36077758-BADABE7A-4328-42AC-BE99-B6378425D712Q36147323-9C3A0549-42F0-47E9-BAE0-A06A28E39F94Q37441445-909EFBAE-C100-4CAA-8CF3-DD3F4E278F15Q37525549-6891628A-E51E-45D1-BAD9-F7C655992828Q38259021-36FB77D5-697F-4648-890C-D7B5C0238375Q38796323-4EF219EA-9885-4581-8A16-EEF681F0ECB5Q42168332-BEB78167-5B87-4E5C-9777-F4F9564BB463Q42682287-F019D801-8E3C-4E8F-BCBF-E61034AA7ADBQ44138898-D1AA4DC7-A463-48CB-A780-3C86F3D6032EQ47215360-16BC9B0F-0E6C-4ADE-83E2-04D5E4C05FE1Q47743424-C00EA907-5C49-4438-9C22-C507C3CA5D21Q48506490-D76D6271-0014-4E5F-A081-D77D3CE7C9EBQ50035831-BC603772-3C38-4A2A-8CB6-71FA717A7AE6Q50047331-E9FDFD0E-CF14-4108-8394-2627AAC99905Q50416466-E6B5E4BD-7889-4275-9AB7-263759EA68D8Q64123067-96EF5765-EDE0-4363-9896-AF1B0B489D37Q64930903-D6C8B177-660F-4B98-8951-6A43533D71E3Q84750807-FF034299-2D91-43A8-89BA-57F8EF3AAB57Q84792553-13D00691-CCDC-44CB-BBCC-C922BF1B64D8Q85239539-03A2E10E-7342-4CB2-8BCA-0BB9312BC7F6Q92443365-DF6AEA7B-0E4B-431C-914B-252CE5AFE7F0Q92600990-43B47F1D-97C4-42A7-998E-E09534930C81Q93340258-D777C829-EED5-4421-A0E2-F4FA211FCBACQ95471287-00C52FFC-17F4-4D81-8CAE-9B7F115F0387Q95511359-66734ECA-6229-4589-9166-DAAD92E23ADFQ95574126-0F89058C-DA39-4440-9D95-8EBC6053C555
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Alex S Evers
@en
Alex S Evers
@nl
type
label
Alex S Evers
@en
Alex S Evers
@nl
prefLabel
Alex S Evers
@en
Alex S Evers
@nl
P108
P31
P496
0000-0002-0342-0575